Login / Signup

Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions.

Anca NenicuYuan GuChristina KörbelMichael D MengerMatthias W Laschke
Published in: British journal of pharmacology (2017)
Combination therapy with telmisartan and a COX-2 inhibitor represents a novel, effective pharmacological strategy for the treatment of endometriosis.
Keyphrases
  • combination therapy